High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance

High-fat diet (HFD) decreases insulin sensitivity. How high-fat diet causes insulin resistance is largely unknown. Here, we show that lean mice become insulin resistant after being administered exosomes isolated from the feces of obese mice fed a HFD or from patients with type II diabetes. HFD alter...

Full description

Saved in:
Bibliographic Details
Published in:Nature communications 2021-01, Vol.12 (1), p.213-21, Article 213
Main Authors: Kumar, Anil, Sundaram, Kumaran, Mu, Jingyao, Dryden, Gerald W, Sriwastva, Mukesh K, Lei, Chao, Zhang, Lifeng, Qiu, Xiaolan, Xu, Fangyi, Yan, Jun, Zhang, Xiang, Park, Juw Won, Merchant, Michael L, Bohler, Henry C L, Wang, Baomei, Zhang, Shuangqin, Qin, Chao, Xu, Ziying, Han, Xianlin, McClain, Craig J, Teng, Yun, Zhang, Huang-Ge
Format: Article
Language:eng
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:High-fat diet (HFD) decreases insulin sensitivity. How high-fat diet causes insulin resistance is largely unknown. Here, we show that lean mice become insulin resistant after being administered exosomes isolated from the feces of obese mice fed a HFD or from patients with type II diabetes. HFD altered the lipid composition of exosomes from predominantly phosphatidylethanolamine (PE) in exosomes from lean animals (L-Exo) to phosphatidylcholine (PC) in exosomes from obese animals (H-Exo). Mechanistically, we show that intestinal H-Exo is taken up by macrophages and hepatocytes, leading to inhibition of the insulin signaling pathway. Moreover, exosome-derived PC binds to and activates AhR, leading to inhibition of the expression of genes essential for activation of the insulin signaling pathway, including IRS-2, and its downstream genes PI3K and Akt. Together, our results reveal HFD-induced exosomes as potential contributors to the development of insulin resistance. Intestinal exosomes thus have potential as broad therapeutic targets.
ISSN:2041-1723
2041-1723